Amylin issues positive Pramlintide data

Data from a mid-stage clinical trial showed its Pramlintide drug helped obese patients achieve progressive weight loss compared with those taking a placebo. Subjects in the 16 week study lost an average 3.6 percent of their body weight with no evidence of a plateau effect.


Amylin issues positive Pramlintide data - Yahoo! News

No comments:

Blog Archive